| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorials |
From the Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia Pa.
Correspondence to Michael Autieri, PhD, Department of Physiology, Temple University School of Medicine, Room 810, MRB, 3420 N Broad St, Philadelphia PA 19140. E-mail mautieri@temple.edu
See related article, pages 1548–1557
Key Words: Krüppel-like factor 4 phenotypic switch proliferation transcription factor
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
B), or proliferation (eg, Egr-1), or differentiation (eg, myocardin).4–6 Is it possible, or even plausible, from a cellular standpoint, that a single transcription factor could potentially play an important part in all 3 of these processes?
| Krüppel Complexity |
|---|
For example, in
Related Article:
Circ. Res. 2008 102: 1548-1557.
This article has been cited by other articles:
![]() |
B. Zheng, M. Han, M. Bernier, X.-h. Zhang, F. Meng, S.-b. Miao, M. He, X.-m. Zhao, and J.-k. Wen Kruppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor {beta}-mediated, Not by Retinoic Acid Receptor {alpha}-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., August 21, 2009; 284(34): 22773 - 22785. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |